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A STRUCTURAL AND BIOCHEMICAL ANALYSIS OF THE 
DROSOPHILA PROTEIN PERIOD 
 
 
Heather Anne King, Ph.D. 
The Rockefeller University 2008 
 
Circadian clocks regulate changes in behavior and physiology that occur 
with a period of approximately 24 hours and are based on negative feedback 
loops.  The molecular components of circadian clocks are conserved 
among animals, and a key element in all such clocks is the protein Period 
(PER), a circadian transcription inhibitor.  The stable production, post-
translational modification, and nuclear translocation of PER all contribute to 
the timing of the clock.  This work describes the synthesis and purification 
of various Drosophila PER fragments for biochemical and crystallographic 
analysis.  Several stable PER fragments are identified, including one 
crystallizable fragment.  The structure of the crystallized fragment is 
provided, and the implications of a critical intermolecular PER-PER 
interaction are explored.   
 
The crystallized region of PER includes the PAS (PER-ARNT-SIM) domain 
(230-512) as well as two subsequent helices (512-575).  Unlike a previously 
published structure for a similar fragment [1], this structure shows a closed 
    
 
PER homodimer that relies on a flexible hydrophobic interaction between 
the final helix of one molecule and the PAS domain of its partner.  
Biochemical and mutational analyses of the crystallized fragment confirm 
the robust yet dynamic quality of this interaction.  A critical residue in the 
dimerization interaction, Valine 243 is positioned at the center of the 
hydrophobic interface.  Previous research has established that a lengthened-
period phenotype in flies is caused by a point mutation at this residue, which 
changes the valine to asparitc acid [2].  Further studies have shown that the 
long period of flies bearing this mutation (perLong flies) results from a delay 
in the PER nuclear translocation [3].  Disruption of the hydrophobic 
molecular interface introduced by V243D suggests the delay in nuclear entry 
associated with perLong may be related to a defect in the PER self-binding 
interaction demonstrated in the crystal structure.  The proximity of the 
observed PER-PER binding interface to the proposed PER-TIM binding 
interfaces also introduces the possibility that PER self binding may affect on 
the PER-TIM interaction.  This work concludes with a proposed model for 
how disrupting the observed PER-PER intermolecular interaction may delay 
nuclear entry.  
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PART 1.  INTRODUCTION 
 
 
1.1  The Discovery of Circadian Clocks 
 
De Mairan, an early circadian biologist 
The term circadian comes from the Latin and means about (“circa”) daily 
(“dian”) and describes phenomena that occur with a rhythm of 
approximately 24 hours.  Circadian behaviors in living organisms have been 
documented as far back as the 4th century BC when an Alexandrian scribe 
wrote about heliotropism, the daily leaf movements of certain plants [4].  In 
the 1700s, Jean de Mairan showed that heliotropes continue to move with a 
near 24-hour rhythm even in constant darkness at constant temperature.  
This work suggested an internal timing mechanism. 
 
Circadian biology in the twentieth century 
Two centuries later, scientists again began to study the phenomena of 
circadian behaviors. Maynard Johnson, like DeMairan, observed circadian 
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rhythms that continued in darkness [5].  He studied the locomotor activity of 
deer mice, which follows a circadian pattern.  The period of these mice 
became slightly longer than 24 hours in constant conditions, which helped 
argue against unseen geophysical forces (which would have more exact 24-
hour cycles) driving circadian behavior.  Some scientists, however, 
continued to argue that external forces, rather than an endogenous 
mechanism, controlled biological timekeeping.  
 
The first light entrainment studies 
Erwin Bunning and Hans Kalmus helped to establish the endogenous nature 
of circadian rhythms and the possibility of  a dedicated biological 
timekeeping system (“ein bioligische Uhr” or “a circadian clock”).  In the 
1930s, their observations of Drosophila eclosion (hatching from the pupal 
case) demonstrated that rhythms could be reset and entrained by light [4].  
The phase of the circadian period followed the light/dark entrainment 
regimen imposed on flies in the laboratory and was not drawn back to real 
time by unseen gravitational or other geophysical force.  Using light as a 
zeitgeber, or time-giver, Bunning and Kalmus could dictate the subjective 
time understood by the animal.  These experiments laid the groundwork for 
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many key experiments later in the century.  One flaw in their work was the 
proposal that circadian timing in Drosophila, unlike other organisms studied, 
was sensitive to temperature [6].  Although temperature sensitivity would 
argue against exogenous control by forces independent of local temperature, 
it would also distinguish the Drosophila circadian rhythm from the 
temperature-independent rhythms described in plants and birds [7].  Further, 
it made little sense that any advantageous system for timekeeping could be 
strongly susceptible to modest fluctuations in temperature. 
 
Establishing general qualities of circadian clocks 
Colin Pittendrigh, who also studied circadian behavior in flies, realized that 
temperature-sensitivity conflicted strongly with his notion of a useful 
internal biological clock.   A temperature-sensitive mechanism would rule 
out his hunch that the sun-compass navigation of starlings, as described in 
Gustav Kramer’s work, was dependent on a general circadian timekeeping 
mechanism [7].  Pittendrigh knew if unifying principals of circadian clocks 
were to emerge, temperature compensation in all clocks would be a 
prerequisite.  He repeated the temperature shift experiments but recorded the 
effects of temperature shifts on Drosophila rhythms for several days.  He 
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concluded that although the circadian period is significantly altered after a 
temperature shift, as Kalmus claimed, this initial response to temperature 
transition lasts only a few cycles before flies regain their original 24-hour 
rhythmicity [6].  Once this hurdle had been overcome, Pittendrigh and his 
colleague, Jurgen Aschoff, began a thorough analysis of formal circadian 
properties which led to his 1960 lecture at the Cold Spring Harbor Symposia 
on Qualitative Biology, “Circadian rhythms and the circadian organization 
of living systems” [8].  Qualities common to all clocks were described, 
including persistence in the absence of environmental input, entrainability 
by zeitgebers such as light, and temperature independence.  This lecture 
helped unite circadian biologists in a common goal – defining a novel 
biological system designed for timekeeping and used to choreograph a 
variety of behaviors and metabolic states. 
 
Locating the clock 
Pittendrigh also participated in the search for the physiological seat of the 
circadian clock, which he located in the optic lobe of cockroaches through 
ablation and transplantation studies [9]. Curt Richter performed similar 
studies in rats and defined the hypothalamus, more specifically the super 
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chiasmatic nucleus (SCN), as the mammalian location of the essential 
pacemaker [10].  Defining clock physiology helped to define its mechanism.  
The ablation and transplantation experiments that established the physiology 
of the clock were the first step toward dissecting the physical substance of 
the clock.  Until then, the output of the clock and the theory of clocks were 
the focus of most research. Irving Zucker described the impact of circadian 
physiologists saying, “Richter succeeded in prying the lid off the circadian 
black box when he showed that unspecified lesions eliminated circadian 
activity and feeding rhythms” [5].   Physiologists acted as the forebears to 
geneticists and protein chemists by tinkering with certain parts of the clock, 
observing the results, and then selectively replacing (transplanting) these 
parts to restore function.  Today this same type of breaking and fixing is the 
essence of work performed by not only circadian physiologists and 
geneticists, but also by biochemists and structural biologists.  
 
Identifying circadian mutants  
Our current understanding of the molecular mechanism underlying the clock 
has depended greatly on two organisms that are well characterized 
genetically and exhibit obvious circadian behaviors - Drosophila 
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melanogaster and Neurospora crassa.  In 1971, Seymour Benzer and Ronald 
Konopka screened randomly mutagenized Drosophila and discovered strains 
of long-period, short-period, and arrhythmic flies [11].  Circadian rhythms in 
eclosion patterns and locomotor activity provided dependable, quantifiable 
data for identifying these mutants.   A similar study was then undertaken 
using Neurospora crassa, producing a comparable period-altered circadian 
mutant [12].  Neurospora crassa has provided a useful model system for the 
study of circadian rhythms because conidation in these filamentous fungi 
occurs once per day according to the circadian rhythm of the organism.  The 
length of filamentous growth between spore bands is directly proportional to 
time, providing a convenient assay of circadian period in this organism.  No 
other systems appeared damaged or altered in the circadian  mutants, 
suggesting the mutated genes were specific to timekeeping.   
 
Cloning circadian genes 
Although a single locus was identified as the cause of observed rhythm 
phenotypes both in Drosophila and in Neurospora, many years passed 
before the actual genes were identified, sequenced, and put to use in further 
defining the clock components.   The Drosophila gene responsible for the 
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phenotypes observed by Benzer and Konopka, was the first to be defined 
[13, 14].  Once this key clock gene, named period (per), could be cloned 
into expression constructs with inducible promoters, a host of new 
experiments became possible, many based on the rescue of rhythms in 
knockouts [15]. Recombinant expression of the Period made the production 
of PER antibody possible, allowing researchers to follow its abundance and 
localization [16]. The Neurospora gene frequency (frq) was also identified 
during this time, so that clocks from two very different species, flies and 
fungus, could be compared at the molecular level [17].   Although the clock 
components of these systems are not homologous, the clocks demonstrated a 
common basic mechanism; a continuous loop of transcription by a specific 
two-component circadian transcription factor followed by repression by a 
clock-specific negative feedback repressor [18].  Variations on this model 
are seen in the circadian clocks of bacteria, plants, and mammals as well as 
flies and fungus.  Among metazoans, circadian components are homologous, 
The similarity between the insect and mammalian systems has facilitated the 
development of molecular models for both systems since the discovery of 
mammalian PER homologs in 1997 [19].  
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1.2  The physiology of the master clock 
The molecular components of circadian clocks are expressed in many cells.  
Overt circadian rhythms, however, depend on synchrony among individual 
cellular clocks.  In complex organisms, this synchrony is established by 
“master clock” cells (also called “pacemaker” cells), which set the phase in 
surrounding cells.  In order to set the phase properly, master clocks utilize 
information about light level, temperature, and nutrient availability.  Stimuli 
that have the power to entrain clocks are called zeitgebers or time-givers.  
The location of pacemaker cells often allows them to be uniquely or 
particularly susceptible to entrainment by certain zeitgebers.  Since light is 
the primary zeitgeber, the master clock is positioned to receive light input.  
In mammals, master clock cells are located in the superchiasmatic nucleus 
(SCN) of the hypothalamus, where they receive light information from the 
retinohypothalamic tract.  In Drosophila, the master clock is found in the 
ventral lateral neurons just behind the optic lobe.  A “local clock,” which 
obeys the master clock but also influences surrounding cells, is found in the 
liver of mammals, where it may sense and relay information about food 
intake.  A local clock is also found in the Malphigean tubes of the 
Drosophila gut.   Local clocks influence several individual organs, but their 
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function depends on the intact structure of the master clock [10].  Pacemaker 
cells align the phases of other cells by transmitting hormonal signals.   
Synchrony throughout the organism influences health and well being and 
depends on communication between master and local clocks.   
 
1.3  The molecular clock  
Circadian clocks are molecular networks based on negative feed back loops 
and have common elements in species from bacteria to plants to animals as 
depicted in Figure 1.1 [20].  Animal clocks depend on highly regulated 
circadian transcription factors that transcribe various output genes as well as 
clock genes [21, 22].  “Negative elements” are inhibitory complexes that are 
modified throughout the 24-hour cycle, first to prevent and then to facilitate 
inhibition of the “positive element,” a transcription factor.  The interplay 
between positive and negative elements of the clock creates an oscillator 
defined by rhythmic peaks and lulls of circadian transcription.  Previously, 
the timing of the clock was understood to depend on the gradual formation 
and accumulation of stable inhibitory complexes.  Recent investigations 
suggest a more complex model, wherein a critical event pushes the cycle 
forward.  This event acts as a rate limiting step to determine the period of the 
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clock, suggesting an “interval timer” model rather than an hourglass [23].   
The timing of such a critical event would depend on a series of 
modifications to the inhibitory element and/or the transcription factor.  
Further defining the positive and negative elements of circadian clocks and 
the modifications involved in such critical events will greatly enhance our 





Figure 1.1.   The basic components of a circadian clock, adapted from [18].  
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1.4  Conservation among clocks   
Since the identification of the first circadian gene, per, in Drosophila, clock 
components have been described in Neurospora, Arabidopsis, 
Cyanobacteria, and Zebrafish as well as in mammals [20, 24-28].   The core 
clock genes are conserved among metazoans, and new clock and clock-
related genes continue to be discovered, especially with the help of 
microarray analyses which have revealed genes whose expression levels 
vary according to a 24-hour cycle.  The basic feedback mechanism of the 
clocks for Neurospora, Drosophila, and Mammals are described below.  The 
Drosophila and mammalian systems are comprised of homologous proteins, 
while the Neurospora clocks consists of interesting counterparts from a 
system that appears to be independently evolved [29].  
 
1.5  The Neurospora clock   
The primary negative element in the Neurospora clock is the protein 
Frequency (FRQ) and the primary positive element is the White Collar 
Complex (WCC), comprised of two PAS proteins: White Collar 1 (WC1) 
and White Collar 2 (WC2) (see Figure 1.2a).  The WCC transcribes a host of 
clock-controlled genes (ccgs), which influence circadian changes in 
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metabolism and reproduction.  FRQ inhibits WCC activity in the morning 
hours with the help of the FRQ RNA helicase (FRH) [30].  Later in the day, 
FRQ promotes the accumulation of stable, inactive WCC complexes.  In the 
evening, FRQ is degraded through the ubiquitin ligase FWD-1 and WCC 
activity is restored.  The light-sensitive PAS protein Vivid (VVD) tunes the 
cycle by disrupting WCC complex formation in the early morning and 
promoting the degradation of frq mRNA in the evening [31].  In this manner, 
VVD tunes the clock by making the onset of circadian transcription more 
gradual in the morning and supports the elimination of FRQ in the evening.  
Many of the interactions of clock components in Neurospora depend on 
regulated phosphorylation and dephosphorylation, a common theme among 
circadian clocks.  A schematic depicting the element of the Neurospora 
clock is provided in Figure 1.2a. 
 
1.6  The Drosophila clock     
The major negative elements of the Drosophila clock are PER and its 
binding partner, Timeless (TIM) (see Figure 1.2b).  PER and TIM are two 
components of an inhibitory complex that also contains several kinases, 
including the PER-bound kinase Double-time (DBT), and may also include 
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other unknown components.  The complex is gradually assembled in the 
cytoplasm throughout the day and in the evening undergoes changes that 
lead to the release of PER from TIM and the subsequent nuclear entry of 
PER, DBT, and TIM [23].   Inside the nucleus, PER/TIM inhibits circadian 
transcription.  PER can also dissociate from TIM and inhibit transcription on 
its own [32].  Dissociation from TIM makes PER a more potent inhibitor but 
leads to PER phosphorylation and degradation in the nucleus as it does in the 
cytoplasm. The major positive element of the Drosophila clock is the 
transcription factor inhibited by PER/TIM and PER.  It is a heterodimer of 
the proteins Clock (CLK) and Cycle (CYC), members of the basic helix-
loop-helix (bHLH) PAS superfamily.  CLK/CYC binds DNA E-box 
promoters that regulate the transcription of per, tim, and other clock-
associated output genes [33].    
 
Other clock components bolster and tune the basic auto inhibition loop 
described above.  The kinase Double-time (DBT), which is part of the 
inhibitory complex, phosphorylates PER and targets it for degradation when 
TIM is not present [34-36].  Casein Kinase 2 (CK2) also phosphorylates 
PER to promote nuclear entry [37-39].   The GSK-3 homolog Shaggy (SGG) 
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has been shown to phosphorylate both TIM and CRY to regulate the clock 
[40].  Light input to the clock is mediated by Cryptochrome (CRY), which 
targets TIM for proteasomal degradation through the ubiquitin ligase Jetlag.  
When CRY destroys TIM, PER is phosphorylated by DBT and degraded 
with the help of the ubiquitin ligase, Slimb (SLMB), an F-box WD40-repeat 
protein that delivers phosphorylated PER to the proteasome [41, 42].  These 
components are listed in Table 1.1.    
 
A secondary feedback loop compliments the primary loop shown above by 
controlling levels of CLK, the limiting factor in CLK/CYC formation and 
circadian transcription [43-45].  This loop depends on the genes vrille and 
Pdp1, which, like per and tim, are transcribed by CLK/CYC.  These genes 
produce an inhibitor (VRI) and a promoter (PDP) of Clk expression.  VRI 
accumulates first and inhibits Clk transcription.  The resulting drop in CLK 
occurs when nuclear PER and TIM are high, further suppressing circadian 
transcription.  As VRI levels taper off, PDP accumulates and reinstates Clk 
expression.  This secondary loop sets up the next inhibition phase of the 
circadian cycle, since CLK/CYC inhibition by PER/TIM is compounded by 
a reduction in CLK levels due to VRI.  In the phase after that, renewal of 
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CLK/CYC transcription is bolstered by a boost in CLK levels due to PDP.  
The secondary loop, therefore, supports and tunes the primary loop by 
aligning the peak in CLK concentration relative to the peak in CLK activity. 
A schematic depicting the elements of the Drosophila clock is provided in 
Figure 1.2b. 
 
Interestingly, it has been shown that different sets of pacemaker cells in 
Drosophila with differential responses to light alternate in dictating the 
overall rhythm [42].   Evening cells, or E-cells, regulate circadian activity in 
light/dark conditions while morning cells (M-cells) drive the clock during 
the constant darkness of free-run.   The  molecular basis of the difference 
between E and M cells appears to involve changes in the interaction between 







    
 
16 
Table 1.1: Components of the Drosophila circadian clock 
Gene Protein Role Interacts With Known domains  
clock (Clk) CLK 
Transcription factor, 
together with CYC 
transcribes clock and 
output genes  
CYC, PER, E 
boxes bHLH, PAS 
cycle (cyc) CYC 
Transcription factor, 
together with CLK 
transcribes clock 
genes and output 
genes 
CLK, PER, E 
boxes bHLH, PAS 
period (per) PER Transcription inhibitor 
TIM, DBT, 
CLK/CYC, 
CRY, SLMB  
PAS, Per C, Per 
S,  NLS (2), CLD 
(2)  








phosphorylates PER,      
targets PER for 
degradation 
PER Ser/Thr kinase 
slimb (slmb) SLMB 
A ubiquitin ligase, 
brings PER to 
proteasome 
PER F-box, WD40 
jetlag (jet) JET 
A ubiquitin ligase, 





Intercepts light and 
causes TIM 
degradation 
TIM, light (via 
flavin), PER Photolyase, PAS 
shaggy (sgg) SGG 
phosphorylates TIM,      
facilitates nuclear 
entry 
TIM Ser/Thr kinase 




2 (ck2) CK2 
phosphorylates TIM,      
facilitates nuclear 
entry 
TIM Ser/Thr (Tyr) kinase 









PDP promotes Clk transcription Clk promoter 
bZIP (PAR 
subfamily) 
*TIM slightly inhibits CLK/CYC [46]  
  
 
1.7  The Mammalian clock 
The primary negative elements of the mammalian clock are the Drosophila 
PER homologs mPER1, mPER2, and mPER3, which bind each other as well 
as the CRY homologs mCRY1 and mCRY2 (see Figure 1.2c).  Although 
mCRY has sequence homology to Drosophila CRY, it behaves more like 
Drosophila TIM by binding, stabilizing, and promoting the nuclear entry of 
the mPERs.  A TIM sequence homolog exists in mammals, but does not 
appear to play a substantial role in the circadian clock [47].  As in the fly 
clock, the positive element of the mammalian clock consists of two bHLH 
PAS proteins that form a transcription heterodimer.  The mammalian 
sequence homolog of CLK is not the limiting factor in the pair.  Rather, the 
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CYC homolog BMAL1 is limiting and cycles.  Neuronal PAS domain 
protein 2 (NPAS2) can also bind BMAL1 to transcribe circadian genes.   As 
in the Drosophila clock, levels of the limiting transcription factor (BMAL1) 
are controlled by a secondary loop [48].  This regulatory loop depends on 
bmal1 inhibition by Rev-erbα to diminish the level of BMAL1 around the 
same time PER/CYC diminishes its activity.  RORa then promotes bmal1 
transcription so that peak BMAL1 abundance coincides with peak circadian 
transcription.  Kinases homologous to Drosophila DBT and SGG also exist 
in the mammalian clock.  Like DBT, mammalian CK1 phosphorylates the 
mPER proteins and targets them for proteasomal degradation via the SLMB 
homolog β-TRCP [49, 50].  The SGG homolog GSK-3 phosphorylates the 
mammalian PER/CRY inhibitory complex to promote nuclear entry and may 
also affect the secondary loop of the clock through its ability to 
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Figure 1.2.   Detailed molecular models of the Neurospora, Drosophila, and 
mammalian circadian clocks as depicted in [53] .  
 
 
     
 
 A. Neurospora     B. Drosophila               C. Mammalian 
 
 
1.8  Human health and the clock 
Circadian clocks have evolved because they allow organisms to predict daily 
changes in light and temperature based on the earth’s rotation.  They confer 
a further advantage by creating what Pittendrigh calls “temporal 
programming” within complex organisms wherein, “the predictable timing 
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of one cellular event determine(s) the optimum time for another” [7].   
Disrupting normal clock function by crossing time zones or working a night 
shift not only prevents the body from anticipating meals, rest, or work 
demands but also upsets the temporal order among biological systems.   
Clocks affect DNA repair and mitosis. Clocks that are constantly disturbed 
by unpredictable circadian regimens (such as rotating shift work) or 
defective components (caused by mutations in clock genes) can lead to 
cancer [54] [55].   Bipolar disorder, schizophrenia, and seasonal affective 
disorder (SAD) have also been linked to the clock [56-58].  
 
The importance of circadian rhythms for overall health continues to be 
supported by the literature and will make structural information about clock 
proteins increasingly relevant in the development of therapeutic targets for a 
range of medical conditions.   Not only could targeted therapeutics help to 
repair compromised clock function, they could also be used to control global 
transcription of clock-controlled genes and prompt broad changes in 
physiological state.  
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The role of PER in the circadian clock  
The 24 hour cycle of the clock can be viewed in terms of the transcription, 
translation, cytoplasmic accumulation, nuclear entry, inhibitory action, and 
subsequent breakdown of PER. 
 
Transcription of per by CLK/CYC  
In the early morning hours, the CLK/CYC transcription factor transcribes 
per, tim, the secondary loop genes vri and Pdp1, and various circadian 
controlled genes (ccgs) that govern circadian changes in behavior and 
physiology.  After a significant delay (6 hours),  per is translated, though the 
mechanism of translational regulation is unknown [59].   
 
Formation of the PER-DBT-TIM (PDT) cytoplasmic complex  
Once PER is produced, it rapidly forms a cytoplasmic complex with TIM 
and DBT that also includes the kinases CK2 and SGG.  The availability of 
TIM determines the stability of PER, because when TIM is not present DBT 
phosphorylates PER to mark it for proteasomal degradation (via the F-box 
protein SLMB).  DBT phosphorylation also plays a role in PER nuclear 
entry [60]. CK2 binds and phosphorylates PER to promote nuclear entry.  
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The GSK3 homolog Shaggy (SGG) binds and phosphorylates TIM to 
promote nuclear entry.  The cytoplasmic complex may include other 
unidentified components.   Its stochiometry and composition are unknown 
and may change throughout the day.  This complex holds PER in the 
cytoplasm for many hours, contributing to the feedback delay that is 
essential for the 24-hour period of the clock.   
 
Nuclear entry 
Nuclear Entry of PER depends on several unknown factors that lead up to 
some critical event that involves the release of cytoplasmic PER and TIM 
into the nucleus.  It has recently been discovered that the separation of PER 
and TIM is one aspect of this release [23].   A pattern of phosphorylation 
events involving DBT, CK2, and SGG has been shown to contribute to 
nuclear entry and may play a key role in the transformation of the 
cytoplasmic complex and the release of PER-DBT and TIM into the nucleus 
[39, 61].  One unexplained aspect of nuclear entry is the formation of 
concentrated bundles of fluorescently-labeled PER and TIM in S2 insect cell 
culture prior to entry, which appear as bright spots, or “punctae” and may 
reflect the sequestering of PER-DBT-TIM (PDT) complexes in subcellular 
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organelles, possibly endosomes, as one step of the nuclear entry process 
[23].  Entry into and exit from these locations would then be aspects of the 
interval timer mechanism, and mutations that delay nuclear entry could be 
viewed in terms of interfering with these events.  Since PDT accumulate 
gradually into punctae and disperse rapidly immediately before nuclear 
entry, release from these punctae would coincide with the separation of PER 
from TIM that occurs during nuclear entry, which may be a critical aspect of 
the interval timer.  A specific importin may carry PER and TIM  to the 
nuclear pore complex, as is the case for the mammalian clock protein 
mCRY2 [62, 63]. 
 
Inhibition of CLK/CYC by PER 
Inside the nucleus, a PDT complex forms again, though some PER remains 
free from TIM.   Although both free and complexed PER are able to inhibit 
CLK/CYC, free PER does so more effectively.  Free PER is susceptible to 
phosphorylation by DBT (and degradation), so that the release of PER from 
TIM, which occurs rapidly when light leads to TIM degradation, both 
encourages CLK/CYC inhibition and ends it.  PER reaches its low point in 
the early hours, and circadian transcription by CLK/CYC begins a new 
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cycle.  Repression of CLK/CYC depends on a region in the C-terminus of 
the protein referred to as the CLK/CYC inhibition domain (CCID) [64].  
This region may act as a scaffold between CLK and the PER-bound kinase 
DBT or another kinase [65].  This mechanism of inhibition has been shown 
in the mammalian and in the Neurospora clock [66, 67].  It was initially 
speculated that PER might interfere with CLK/CYC transcription by binding 
one protein or the other through its PAS (Per-Arnt-Sim) domains in order to 
separate the two, but this was proved false [33].  Therefore, the function of 
the PER PAS domains remains unclear.  
 
Figure 1.3.   A basic schematic of the 24 hour PER cycle.  The CLK/CYC 
transcription factor is shown in orange and yellow.  PER is shown in purple 
and TIM is shown in blue. 
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1.10  The PER protein  
The PER PAS domains are found in the N-terminal half of the protein and 
between residues 240 and 512 (of 1224).  These are the only regions of 
known structural homology, however, many other regions of PER have been 
characterized by their functionality.  Residues responsible for binding other 
proteins or nuclear/cytoplasmic localization have been identified as well as 
residues that are phosphorylated by DBT and CK2.  These are summarized 
on the function domain map in Figure 1.4, as are point mutations whose 
circadian phenotypes have been well characterized.  
 
Figure 1.4.   A Functional Map of the PER Protein 
 




A more extensive list of PER features, such as binding regions, residues 
involved in point mutations, or residues that undergo regulated 
phosphorylation is provided in Table 1.2.  Some features can be categorized 
according to what step of the PER cycle they affect. Some mutations or 
deletions affect several steps, so that the overall effect on rhythm must be 
dissected to properly interpret the behavioral change.   
 
Table 1.2:  PER features 
Feature Location Involved with 
Nuclear localization sequence 1- 95 Nuclear entry 
SLIH mutant, (long rhythms, 
shorter with heat) 
S45Y Temperature compensation 
Interaction with DBT 1- 365 Phosphorylation, Degradation  
CK2 phosphorylation facilitates 
nuclear entry 
149-151 Nuclear entry 
Pas A domain 240-293 TIM binding (TIM 507-578) 
Long mutant V243D Nuclear entry, Temperature 
compensation 
Pas B domain 365-454 Unknown 
Cytoplasmic localization domain 
(CLD) 
448-512 Localization, TIM binding 
(TIM 715-914) 
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“Short” domain, regulated 
phosphorylation affects stability 
585-600 Phosphorylation, Degradation  
Short mutant S589N Nuclear Stability  
Interaction with CRY 524-685 Stability following light pulse, 
Interaction with TIM 
PER DBT (1-292) binding 
domain 
765-800 DBT binding, Phosphorylation 
dCLK:CYC inhibition domain 764-1034 Inhibition of CLK/CYC 
Second NLS  822-837 Nuclear Entry 
Clk mutant A969V Stability 
 
 
PAS domains within PER 
The PAS A and B domains of PER (shown in white in Figure 4 and listed in 
Table 2) follow the canonical PAS fold, which consists of a five-strand beta 
sheet sitting beneath a cluster of 4-5 alpha helices.  The typical fold and 
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Figure 1.5.   The Typical PAS Fold and Nomenclature as seen in the Human 




PAS stands for PER as well as ARNT, the aryl hydrocarbon receptor nuclear 
translocator protein (ARNT), and SIM, the Drosophila Single-minded 
protein.  The PAS domain was initially defined as a 270 amino acid region 
containing a pair of highly conserved spans termed PAS A and PAS B.  
Later, when unpaired and multiple PAS repeats were discovered, the PAS 
definition was modified to describe single amino acid sequences with highly 
conserved N-termini [69, 70].  Since then, PAS domains have been found 
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throughout species from bacteria to mammals, and are predominantly 
located within cytosolic sensory proteins [69].    PAS domains fall into two 
broad categories, those that transmit information about light, oxygen levels, 
and voltage (also called LOV domains), and those that acts as protein-
protein binding interfaces.    
 
Structural data about PAS domains come from crystallized proteins, 
including the photoactive yellow protein (PYP) [71, 72], the N-terminal of a 
human potassium channel (HERG) [68], the FixL bacterial oxygen sensor 
[73, 74],  and the LOV2 photoreceptor in plants [75].  These structures 
demonstrate a common α/β fold, however, the activity and specificity of 
each PAS domain is regulated by flanking domains and or co-factors [76].   
Each structure shows a single PAS domain, and all except HERG include 
cofactors.   
 
PAS domains and circadian clocks 
PAS domains are found in the PER, CLK, and CYC Drosophila clock 
proteins as well as in their mammalian homologues. Table 3 lists PAS 
proteins involved in the Drosophila clock and in the human clock. 
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Table 1.3: PAS proteins involved in Drosophila and Mammalian Clocks 
 
Organism Gene Protein PAS Interacts With 
Drosophila Period (per) PER TIM, CLK/CYC,  
Drosophila clock (Clk) CLK CYC, PER,  
Drosophila cycle (cyc) CYC CLK, PER, 
Human Period1 (per1) hPER1 CRY1&2, PER1-3 
CLK/BMAL, 
CLK/NPAS2 
Human Period (per2) hPER2 CRY1&2, PER1-3 
Human Period (per3) hPER3 CRY1&2, PER1-3 






Human (nPAS2) NPAS2 CLK 
Human clock (Clk) CLK BMAL1, NPAS2 
 
 
PAS domains are also found in the circadian clock proteins of 
Cyanobacteria, Arabidopsis, and Neurospora.  In Drosophila clocks, PAS 
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domains are thought to mediate protein-protein binding between PER and 
TIM and are not known to bind co-factors.  In mammalian clocks, PAS 
domains are also known to mediate protein-proteins interactions.  
Additionally, the mammalian transcription factor NPAS2 binds a heme 
cofactor, and a murine PER (mPER2) may also bind heme [77, 78].    
 
The PAS domains of the mammalian PERs 
The mammalian PER homologues mPER2, and mPER3 contain tandem 
PAS domains with strong homology to the Drosophila PER PAS region.  
Elimination of the mPER2 PAS B domain in mPer2BrdmI mutants (Δ348-434) 
leads to shortened rhythms in light/dark (LD) entrainment and arrhythmicity 
in constant darkness, suggesting the importance of the PAS domains in clock 
function [79] .   Homodimerization and heterodimerization are known to 
occur in mammalian PERs, and likely occur via PAS-PAS interactions [80].  
The N-terminal half of the mPER3 protein, which contains the PAS region 
and no other known protein interaction domains, is sufficient for 
heterodimerization with mPER1 and mPER2.  Heterodimerization of mPERs 
regulates nuclear entry [81].  Binding between mPER3, which contains a 
nuclear localization sequence (NLS), and either mPER1 or mPER2 is shown 
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to facilitate nuclear entry in cell culture.  In a separate study, nuclear mPER1 
formed heterodimers with co-expressed mPER2 and became cytoplasmic.  
The PAS region of mPER3, which contains an NLS, is responsible for 
holding this protein in the cytoplasm.  When the PAS domain is deleted, 
mPER3 localizes to the nucleus.  
 
The PAS domains of PER 
Although the discovery of PAS structural homology in PER was hailed “a 
landmark in the molecular map of circadian clocks,” the role of the PER 
PAS domains is not yet known [82].  PER does not appear to inhibit 
CLK/CYC through PAS-PAS interactions that separate original heterodimer, 
as was originally suspected [33].   Furthermore, the PAS domains of PER 
are not part of the region determined by deletion analysis to be critical for 
inhibiting CLK/CYC [64].  Rather the PER PAS domains are required for 
binding TIM, which has no PAS sequence homology [83].  A hydrophobic 
residue in the PER PAS A domain (Valine 243) is mutated in perLong, which 
exhibits delayed nuclear entry, suggesting this domain may be involved in 
nuclear entry, either directly or through an effect on the PER-TIM 
interaction.  Interestingly, the PER-TIM interaction appears to be 
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strengthened rather than diminished in perLong. [84] The cytoplasmic 
localization domain (CLD) of PER is also located in the PAS region.  It is 
the beta sheet of the PER PAS B domain.  Removing this domain holds 
otherwise nuclear PER in the cytoplasm.  The beta sheets of PAS domains 
often mediate binding interactions, and deletion analysis shows that the PER 
PAS B beta sheet (residues 448-512) is necessary for an in vitro interaction 
between PER and TIM 715-914.  A crystal structure of the PER PAS 
domain region of PER indicates PAS-PAS interactions could create PER 
oligomers, though the primary intermolecular interface is non-symmetrical 
which leads to the formation of octamers [1].  A new crystal structure, 
presented in this work, shows a symmetrical PAS-PAS interaction between 
PER molecules, leading to separate dimers.  This structure demonstrates 
how the PAS domains can act as homodimeric interfaces between PER 
molecules, while leaving open areas identified as necessary for TIM binding.  
The homodimerization interface demonstrated in this structure uses an 
interesting mechanism that may allow multiple conformations and invite 
change or modification in interactions between PER and TIM or PER and 
the entire PER-TIM-DBT complex. 




PART 2: MATERIALS AND METHODS 
 
2.1  Molecular Biology 
Period fragments were cloned from existing  PER constructs for 1-700 and 
1-1021 into pGEX6P3 using BamH1/Not1 cut sites to position the PER 
sequence downstream from the GST fusion protein.  A stop codon was 
introduced into each fragment with the 3’ oligomer.   The oligomers used for 
polymerase chain reaction (PCR) to create the crystallized fragment are 
shown below.   
 
at residue 229:                BamH1 site 
5’ oligomer         AGA  GGA  TCC   CAG  CGC  GGG  GAG  CGG  GTG  AAG  GAG    
                       overhang              G        Q        R       G        E        R       V       K        E 
 
at residue 575: 
5’  CGG  GCG  GAT CTC AAG CTG GAG TAA  GCG GCC GCA GAG  
R       A       D       L      K       L      E    stop  
        overhang 
                                         NotI site  
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Following PCR and purification of PCR products, cutting with BamH1 and 
Not1 took place at 37˚C for 3-14 hours.  Gel purified digested PCR products 
were ligated into cut plasmid at 16 ˚C overnight or at 21˚C for three hours.  
The ligation product was transformed into XLI cells by heat shock at 42˚C.  
Successfully transformed colonies were grown in 2 ml cultures to 
confluence, and vector DNA was extracted and purified using ion exchange 
minicolumns (Qiagen miniprep kit).   Extracted DNA was cut by BamH1 
and Not1 to verify incorporation of the PCR product.  All other constructs 
were prepared similarly.  Point mutations were introduced into pGEX6P3 
using the QuikChange mutagenesis system (Stratagene). All clones were 
verified by sequencing. 
 
2.2  Protein Expression and Purification  
Vectors as described above were transformed into E. coli BL21 (pLysS), a 
chloamphenicol resistant E. coli strain that expresses T7 lysozyme to 
suppress basal expression of T7 RNA polymerase, thereby restricting 
expression of target protein prior to controlled induction with IPTG.  T7 
lysozyme also aided in lysis while the presence of chloramphenicol in stocks 
and cultures reduced the risk of contamination.  As described in Figure 2.1, 
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transformed pLysS cells were grown to confluence overnight with shaking 
in LB with 50 micrograms/ml ampicillin or carbenicillin and 35 
micrograms/ml chloramphenicol.   Larger flasks of LB were inoculated with 
0.2% v/v confluent culture and shaken at 37˚C to OD = 0.6 to 0.9 before 
induction with 0.5mM isopropyl-beta-D-thiogalactopyranoside (IPTG).  
After induction, the temperature was lowered to 20˚C, and cells were shaken 
for an additional 20-22 hours.  Cells were collected by centrifugation at 
5,000g for 10 minutes and resuspended in Buffer 1 or Buffer 2 (Buffer 1 = 
50mM Tris (pH 7.5), 150mM NaCl, 3mM DTT, Buffer 2 = 50mM Tris (pH 
7.5), 500mM NaCl, 3mM DTT).  
 
EDTA-free protease inhibitor tablets (Roche) and recombinant DNAse 
(Roche) were added to the resuspension before freezing at -80˚C. Frozen 
cells were thawed with stirring at room temperature with 5% of a 10x 
detergent solution (Bug Buster).  For preparations of fragments including 
residues 1-80,  which strongly bind DNA (discussed in Part 3), 1 microliter/ 
20ml resuspension RNAse cocktail with 1mg/ml RNAse A and 20,000U/ml 
RNAseT1 (Ambion) was added.  The thawed lysate was passed through a 
syringe to shear DNA and incubated at 4˚C for 30 to 50 minutes until the 
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degradation of nucleic acid reduced the lysate viscosity sufficiently for 
centrifugation.  Soluble protein was separated from solids by centrifugation 
at 20,000g for 45 minutes, and the resultant supernatant was incubated with 
1-2 mcrl/ml 30% polyethylene amine (PEI) for 20 minutes on ice.  Addition 
of PEI served to precipitate remaining nucleic acid from the soluble 
component.  The supernatant was then respun at 12,000g to precipitate PEI-
bound solids and filtered at 0.42 micron before adding rinsed, equilibrated 
glutathione sepharose beads (1 ml bead/Liter of culture).  The bead and 
protein solution was nutated at 4˚C for 1 hour and the beads were spun down 
at 1,000g.  The supernatant was then removed as “flow through” and the 
beads rinsed in batch (two 30ml rinses of Preparation Buffer per 1.5ml 
beads).  Beads were then transferred to a column and rinsed with 10-12 
column volumes more buffer, and Prescission protease was added (5-10 
units per/ Liter culture) in a 1mM EDTA buffer. The column was left 
overnight at 4˚C.  Eluted protein was concentrated using spin columns 
(10,000KD cutoff) and then run on Superdex 200 sizing column.  Peak 
fractions were collected and analyzed for purity by PAGE.  The most pure 
fractions were collected, concentrated, and exchanged to an appropriate 
buffer for crystallization trials (for the crystallized fragment, 20mM Hepes 
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(pH 7.7), 200mM NH4HCO3 was used).  Hampton Crystal Screen and PEG 
screen were used as the initial screens for crystallization trials. 
 
Figure 2.1.   Standard purification protocol developed for purification of 









2.3  Protein analysis by SDS PAGE 
Protein samples were separated according to their electrophoretic mobility 
using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS 
PAGE).  Gels were made with 6,8, and 4-12 (gradient)% acrylamide in 
bis/tris buffer and run at a constant voltage of 150-200mV.    
 
2.4  Analytical Chromatography 
Analytical gel filtration chromatography of affinity-purified PER fragments 
was performed using a SMART FPLC system with a 3.2/30 Superdex 200 
column (Amersham Biosciences). Columns were pre-equilibrated with 
Buffer 1 or 2 (see above). Protein elution was monitored by measuring 
absorbance at 280 nm.  In some cases, DNA elution was also measured by 
absorbance at 260.  A calibration curve was generated by measuring the 
elution volumes of standard proteins of known molecular mass (Bio-Rad) 
shown below in Figure 2.2. Molecular masses of PER fragments were 
estimated based on elution volume and weight of the monomer as indicated 
by PAGE analysis of peak fractions.  
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Figure 2.2.   A chromatogram showing the elution peaks of known 
molecular weight standards run on a Superdex 200 3.2/30 SMART column. 
Elution volumes as a percentage of column volumes are consistent with 




2.5  Crystallization 
Crystals of PER 229-575 were grown at 20°C in hanging drop setups using a 
reservoir solution with 200mM lithium chloride, 20% PEG 3350 (15% PEG 
if seeded), 100mM Bicine (pH 9.0) and a protein solution with 5 mg/ml PER 
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229-575 in 20mM HEPES (pH 7.7), 200mM NH4HCO3, and 5mM DTT. For 
X-ray data collection at 100 K, crystals were transferred in several steps into 
a cryoprotecting solution containing 20% Glycerol (v/v), 200mM lithium 
chloride, 20% PEG 3350, and 100mM Bicine (pH 9.0) and shock frozen in 
propane. SeMet crystals were treated similarly. 
 
2.6  Data Collection, Structure Determination, and Refinement 
The crystals belong to space group P1 with cell constants a=60.4 Å, b=94.7 
Å, c=141.0 Å and α=88.2°, β=89.6°, γ=89.9° and two molecules per 
asymmetric unit.  Data to 2.85 Å resolution were collected from a single 
PER 229-575 crystal at 100 K using the BL8.2.1 beamline at ALS.  The data 
set was processed with HKL2000. Molecular replacement with 1WA9 
(residues 236-540) was used to calculate the phases. The 2.85 Å map was 
obtained after iterative rounds of model building into 2Fo - Fc and Fo - Fc 
maps and refinement using bulk solvent correction, positional, torsion angle 
simulated annealing, and grouped B factor refinement protocols of CNS.   
The model consists of 2,579 amino acids and 12 water molecules.  Some 
residues in the loop regions are not seen in the electron density due to 
conformational disorder.  Figures were generated using PyMOL. 
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PART 3: PURIFICATION OF STABLE PER FRAGMENTS 
 
For crystallization trials and some chromatographic assays, several 
milligrams of highly pure protein are required.  Such quantities of PER 
cannot be purified from Drosophila or from insect cell culture in a cost 
effective manner.  In order to express large quantities of PER, fragments 
amenable to overexpression in E. coli must be determined.  Fragments were 
selected to maximize the number of interesting functional domains or known 
mutations, many of which occur in the first 700 residues (see Figure 1.4).  
 
The presence of domains of interest was balanced against the likelihood of 
successful crystallization.   Sequence alignment (Blast, T-coffee) and 
secondary structure analysis (Predict Protein) were used to select N and C 
termini with strong alignment to homologous proteins and predicted 
structural elements.   Constructs for expression of these fragments were 
prepared as described in Part 2, and small-scale induction trials helped to 
determine expression levels of various constructs.  Solubility tests were then 
performed to show the partitioning of protein between the soluble fraction 
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and the insoluble cell pellet following lysis.  Finally, small scale (50mL) 
affinity purification assays narrowed the pool of fragments to those that 
could be moved forward to large-scale preparations.  Several stable 
fragments can be purified in large quantities, and extensive crystal screens of 
these fragments yielded crystals for the PER 229-575 fragment.   
 





PER fragments fit for preparation of larger quantities (500mL-1L) are listed 
in Table 3.1.   Of these, some strongly bind nucleic acid.  Removal of N-
terminal residues 1-87 eliminates nucleic acid binding.  Truncation of the N-
terminal 87 residues eliminates nucleic acid binding but leads to degradation 
of the C-terminus.  These issues are described in Sections 3.1-3.2.  One 
highly stable PER fragment neither binds DNA strongly nor degrades from 
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the C-terminus. This is PER 229-575, which can be crystallized using the 
method described in Section 3.3.   
 
Table 3.1 PER fragments that are soluble and can be purified in large 










1-848 Yes Slight Yes No 
1-700 Yes Slight Yes No 
1-629 Yes Slight No No 
1-575 Yes Slight Yes No 
87-700 No Yes Yes No 
87-848 No Yes No No 
147-692 No Yes Yes No 
147-573 No No Yes No 
170-700 No Yes Yes No 
205-692 No Yes Yes No 
229-848 No Yes Yes No 
229-628 No Yes Yes No 
229-575 No No Yes Yes 
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PART 3.1 The N-terminus of PER binds nucleic acid  
 
PER fragments that include residues 1-87 bind nucleic acid strongly, 
forming large soluble aggregates and hindering purification.  RNAse 
treatment reduces the aggregation, as does increasing the salt concentration 
of the purification buffer.  The resultant proteins are stable and pure but do 
not crystallize.  Eliminating the N-terminal 87 residues of PER solves the 
problem of aggregation and the need for higher salt and RNAse treatment 
during purification but introduces a new problem - instability and proteolytic 
cleavage of the protein. 
 
Data: 
PER 1-700 forms a large, soluble aggregate and runs in the void of gel sizing 
columns, preventing further purification following affinity purification.  The 
OD 260 reading of the chromatogram in Figure 3.1.1 indicates the presence 
of nucleic acid, and samples of PER 1-700 run on agarose gels are stained by 
ethidium bromide.  Tandem equivalent purifications of 1-700, 147-573 and 
147-692, show that although affinity purified PER 1-700 is strongly stained 
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PER 147-573 and 147-692 are not.  Residues 692-700 are not responsible for  
nucleic acid binding since PER 1-568 also binds nucleic acid (Figure 3.1.1).  
DNAse versus RNAse assays performed on affinity purified PER 1-700 and 
phenol extractions of purified PER 1-700 indicate that RNAse A/T1 cocktail 
breaks down the nucleic acid present, but DNAse does not (Figure 3.1.2).  
Stringent treatment of affinity purified PER 1-700 and PER 1-568 with 
RNAse eliminates aggregates, as seen in the change in the chromatograms of 
PER 1-700 and PER 1-568 following RNAse treatment (Figure 3.1.3); 
however, PER fragments that include the N-terminus and are purified in the 
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Figure 3.1.1.   Affinity purified PER 1-700 prepared in 150mM NaCl buffer 
runs as a large soluble aggregate on gel sizing columns.  A. PER 1-700 runs 
in the void volume of a superdex 200 sizing column with strong OD 260 
absorbance B. PAGE SDS analysis of eluted PER 1-700 C. Eluted PER 1-
700 run on agarose gels shows strong ethidium bromide staining. 
 






A.                                                                                    B.                                      C.    
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Figure 3.1.2.   Affinity purified samples of 1-700, but not 147-573 or 147-
692, are strongly stained by ethidium bromide.   A. SDS PAGE gel with 1. 
Affinity purified PER 1-700, 2. Affinity purified PER 147-575, 3.   Affinity 
purified PER 147-573.   B. 1% Agarose gel with equivalent samples to A   
C. SDS PAGE showing four equivalent samples of 1-700 from A treated 
with 1. nothing, 2. Recombinant DNAse, 3. RNAse A + T cocktail, 4. 
Benzonase nuclease (a non-specific endonuclease)  D. 1% Agarose gel with 
equivalent samples to C.  
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Figure 3.1.3.   Treatment with RNAse cocktail (described in Part 2) breaks 
up the aggregates formed by PER 1-700 and by PER 1-575.  A.  As above, 
affinity purified Per 1-700 runs in the void volume of a Superdex 200 sizing 
column (>700,000kD).  Following RNAse treatment,  the aggregate is 
broken up, and the protein can be separated from impurities. B. Similarly, 
PER 1-568 behaves as an aggregate unless treated with RNAse.  C.  Using 
RNAse treatment along with a higher salt purification buffer (500mM versus 
150mM NaCl), PER1-700, 1-575, and 1-848 can be prepared using the 











In order to purify PER fragments including residues 1-87, high salt and 
stringent RNAse treatment must be used.  Even following such treatment, 
purified PER fragments that include the N-terminus do not crystallize after 
extensive screening.  Failure to crystallize may or may not result from 
residual nucleic acid binding.  To avoid nucleic acid binding, the N-terminus 
can be eliminated.  
 
 
PART 3.2 Eliminating the N-terminus of PER destabilizes PER 
fragments that extend beyond residues at or around 570. 
 
PER fragments that include residues 1-87 bind nucleic acid and form 
aggregates that hinder purification.  Eliminating the N-terminal 87 residues 
of PER fragments does solve the problem of aggregation, but introduces a 
new problem - instability and proteolytic cleavage of the protein.  PER 
fragments lacking the N-terminus, including 87-695, 87-848, 147-692, and 
170-700 are unstable.  Edman sequencing followed by mass spectrometry of 
the smallest degradation product of PER 170-700 indicates that this 
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fragment has an intact N-terminus beginning at 170 but a degraded C-
terminus that ends at or around residue 570.  This is consistent with the 
stability of the N-terminally truncated fragments 147-573 and 229-575, 
while similar proteins such as 147-692 and 229-848 are unstable and 




Eliminating the N-terminus strongly reduces nucleic acid binding but causes 
protein instability.  PER 87-695 does not form large soluble aggregate and 
The OD 260 trace of the chromatogram shown in Figure 3.2.1 does not 
indicate nucleic acid binding.  The resultant protein is unstable, however, 
and degrades from 67 kD to a finite size around 50kD.  The same type of 
degradation is seen in PER 87-848, but not 1-848.   Proteolytic cleavage is 









Figure 3.2.1.   N-terminally truncated PER does not aggregate but degrades. 
A. Per 87-695 can be purified by gel sizing chromatography without high 
salt or RNAse treatment B. Purified 87-695 is unstable and degrades.  C. 
PER 87-848 is unstable compared to PER 1-848. 
 
 






A.                 B.                                   C. 




Figure 3.2.2.   A. PER170-700 is less stable than PER 1-700 and shows 
similar patterns of degradation to 87-695 and 87-848.  The smallest 
degradation band of PER 170-700 was submitted for Edman sequencing and 
mass spectrometry, and results indicate this band begins at residue 170 and 
ends at or around 570.  B. 147-692 shows a similar pattern of degradation 








A.                                                 B.                               C. 





To avoid nucleic acid binding, the N-terminus of PER fragments can be 
eliminated, but this leads to degradation.  The smallest product of this 
degradation in PER 170-700 begins at 170 and ends at or around 570.  C-
terminal degradation of N-terminally truncated fragments is consistent with 
the pattern of degradation seen in PER 87-695, 87-848, 147-692, and 170-
700 as well as the stability of PER 147-573 and PER 229-575 (depicted in 
section 4).   The following table describes PER fragments that appeared to 
be good candidates for crystallization following initial screens, problems in 
large-scale purification of these proteins and the one successfully 
crystallized fragment, PER 229-575.   It is interesting to consider the 
possibility that the N-terminus of PER physically interacts with residues 
following 570 in the “short/mutable” region of PER (585-600).   A variety of 
mutations in this region shorten the circadian rhythm in vivo [85] .  This 
shortened rhythm comes from more rapid turnover of nuclear PER.   If the 
N-terminus of PER interacts with the short/mutable region in vivo, mutations 
in the PER short region may destabilize PER by interrupting this interaction. 
 




PART 3.3: Crystallization of PER 229-575 
 
PER 229-575 produces stable, reproducible crystals with strong diffraction 
when prepared and crystallized as described in Part 2.  A mutant version of 
PER 229-575 carrying the perLong mutation (V243D) could not be 
crystallized.  This and other versions of perLong: V243D, V243R, and 
V243N, were far less soluble than wild type and ran as monomers or in a 
monomer-dimer equilibrium near monomer.  The failure of these mutants to 
dimerize becomes apparent by looking at the position of V243 in the crystal 
structure.  The effect of V243D on PER dimerization and its position in the 
crystals structure are discussed further in sections 4.6 and 6.  
 
Data: 
As shown in Figure 3.3.1, PER 229-575 can be purified cleanly and runs at 
approximately dimer molecular weight, though slightly smaller (some 
monomer-dimer equilibrium).  The chromatogram in Figure 3.2.1 is from a 
column run in 150 mM salt, and PER 229-575 runs as a strict dimer only in 
500mM NaCl.  Purified PER 229-575 is quite clean, though after several 
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days a small band appears 2-3kD beneath the full-length fragment band, 
consistent with the loss of αF (residues 550-575).  This underband does not 
appear when protein crystals are analyzed by PAGE.  Crystals of PER 229-
575 form overnight using the method described in section 2.  
 
PER 229-575 V243D is far less soluble than the wild-type.  The degradation 
band seen in wild-type protein is present from initial purification in V243D 
and far more prominent.  The V243D protein runs in two peaks, one at a 
weight consistent with a monomer-dimer equilibrium and the other 
consistent with a strict monomer.  Peak fractions indicate that the monomer 
peak consists of the slightly degraded protein.  PER 229-575 V243D does 
not crystallize under conditions similar to those used for PER 229-575 nor 











Figure 3.3.1.   PER 229-575 purified by Gel Filtration:  A. This fragment 
runs close to dimer size on gel filtration.  Lines labeled “D” and “M”  
indicate peak volumes consistent with the dimeric and monomeric molecular 
weights.   B. Lane 1 shows a peak fraction of 229-575 from a gel filtration 








A.                                                               B.                           
1          2 
D   M                         
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Figure 3.3.2.   PER 229-575 crystallizes overnight at room temperature.        
A. Without seeding, PER forms large plates.  B. With streak seeding, small 
single crystals grow, C. and D. Seeding with a stock solution produces larger 
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Figure 3.3.3.   PER 229-575 V243D does not behave as PER 229-575:  
A. Gel sizing chromatogram of PER 229-575 V243D prepared and run 
under similar conditions to PER 229-575 depicted in Figure 3.3.1.  There are 
more impurities and the protein peak contains two peaks.  The first peak at 
1.55 ml indicates a dimer-monomer equilibrium and the second peak at 1.61 
ml indicates a monomer.  B. SDS PAGE analysis of the affinity purified 
protein (Lane 1) shows impurities including a 59 kD protein consistent with 
a heat shock protein identified in other preparations.   Lanes 2-12: fractions 
of the protein peak show two populations of protein, one full length 
(indicated by upper arrow) and the other slightly degraded (indicated by 
lower arrow).  The degraded protein elutes at a volume consistent with the 
molecular weight of the monomer (38kD).     
 
 
A.                                                                           B.                           




PER 229-575 forms a dimer in solution.  This protein crystallizes readily at 
room temperature overnight in the condition described in Part 2. The perLong 
point mutation, V243, disrupts dimerization of PER 229-575 and 
destabilizes the protein.  The undegraded V243D protein elutes from gel 
sizing columns at a volume consistent with a monomer-dimer equilibrium 
while the degraded band runs as a monomer.  PER 229-575 V243 cannot be 
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PART 4: THE CRYSTAL STRUCTURE OF THE PER PAS DOMAIN 
REGION (229-575) 
 
The crystal structure of the PER PAS domain region includes the PAS A 
domain, the PAS B domain, and two helices that extend beyond the PAS 
domains referred to as αE and αF.   Each of the PAS domains seen in the 
structure follows the standard PAS fold as described in Part 1 (Figure 1.5), 
and can be described using the standard nomenclature.   
 
Figure 4.1.   The PAS fold seen in the PAS A & B domains of the PER PAS 
region.  A. The PAS domain from HERG as depicted in [68] .  B. The PER 




             A.                                               B.                                       C 
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4.1: The asymmetric unit 
 
The asymmetric unit is comprised of eight molecules arranged in four nearly 
identical dimer pairs (AB, CD, EF, and GH).  Although the structure was 
solved in the P1 symmetry group, it has near monoclinic symmetry that can 
be seen in the near 90 angles of the β and γ cell dimensions (α=88.2°, 
β=89.6°, γ=89.9°).   Systematic absences in the structure factors implies a 
screw axis, which can be observed in the relationship between dimer pairs. 
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Figure 4.1.1.   The four dimers of the asymmetrical unit. The red/blue dimer 












4.2: The dimer unit  
The basic unit of the PER PAS domain region structure is a dimer consisting 
of four PAS domains.  As described in Part 1, each PAS domain consists of 
four helices sitting atop a 5-strand beta sheet.  The PAS A and B domains of 
each molecule are connected by a loop, and the second PAS domain is 
followed by two helices. Unlike a previously published structure of the PER 
PAS region, which shows an octamer of four joined dimers, this structure 
shows dimers that are self-contained and held together by symmetrical 
dimerization interactions.  These include intramolecular and intermolecular 
PAS-PAS interactions and an interesting intermolecular interaction between 
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Figure 4.2.1.   Comparison of this structure versus another [1].  A. In this 
structure, PER dimers are held together by symmetrical PAS-PAS 
interactions and helix/PAS A interactions.  Note the proximity of the N 
terminus (residue 236) of one molecule to the C terminus  (residue 571) of 
the other, consistent with the possibility of an interaction between the N-
terminus and residues 570-600.  B. In [1], only one helix/PAS A interaction 
takes place and the other helix and PAS A surface participate in interactions 
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4.3: PAS-PAS intermolecular interactions  
The four PAS domains of the dimer sit in a ring with hydrophobic 
interactions between the PAS A domain of molecule 1 and the PAS B 
domain of molecule 2 that are repeated between the PAS B domain of 
molecule 1 and the PAS A domain of molecule 2.  These hydrophobic 
interfaces occur between a highly conserved tryptophan (W482) in the PAS 
B domain βD-βE loop and a pocket on the helical face of the PAS A domain 
of the partner molecule containing Glycine (G248), Serine (S273), and 
Isoleucine (I275). Similar interactions are seen in the previous structure.   
The tryptophan (W482) is conserved in other PERs, mPERs1-3, CYC, 
BMAL1, and mCLK.  In Drosophila CLK, phenylalanine (F) replaces 
W482.  In other tandem PAS domain proteins, such as AHR, Arnt, and SIM, 
this tryptophan is not conserved.  The PAS A interacting residue G248 is 
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Figure 4.3.1.   Detailed view of the PAS-PAS symmetrical intermolecular 
interaction between W482 and G248, S273, and I275 from dimer GH.  A. 
The location of the detail relative to the dimer.  B. Detailed view of W482 
from the βD-βE loop of PAS B in the pocket including G248, S273, and 
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4.4  PAS A/αF intermolecular interactions 
Helix F (αF) extends across the PAS dimer ring from the C-terminal end of 
one molecule to the PAS A beta sheet of the other, forming a key 
intermolecular interface based on interactions between hydrophobic residues 
on the PAS A beta sheet and αF.  When αF is deleted (229-512), the PAS 
domain region fragment (PER 229-575) runs as a monomer on gel filtration 
[1].   The participating hydrophobic residues on the PAS A beta sheet lie in a 
row across the strands. They are Tyr 253 (on βB), Valine 243 (on βA), 
Valine 367 (on βE), and Valine 343 (on βD).    A disulfide bond between 
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Figure 4.4.1.   The F helix interacts with the PAS A domain of the partner 
molecule to form a large hydrophobic interface: A. Overview of the dimer 
with arrows indicating the Pas A/ F helix interactions,  B. Close up of the F 
helix of molecule B against the Pas A beta sheet of molecule A, C. F-helix 
residues involved in the interaction, D. PAS A residues involves in the 
interaction.    
 
            
 
 
A.       B. 
C.       D. 




4.5 Flexibility in the PAS A/αF interaction  
The structure reported here shows a symmetrically closed dimer, with both F 
helices bending in to lie across the PAS A domain of the dimerizing partner.  
This is unlike the previous structure in which the F helix of one molecule 
does not bend in but sticks out straight to bind the PAS A domain of another 
dimer pair in a manner that groups dimers into octamers.  Although both F 
helices form similar intermolecular dimerization interfaces in the dimer, 
there are differences in the position of the helix on the beta sheet.  The same 
key residues (shown in Figure 4.4.1) participate.   However, the helix on one 
side of the dimer appears shifted one turn relative to the PAS A beta sheet.  
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Figure 4.5.1.   Differences between the two PAS A/ αF interactions of the 
dimer shown in molecule A and molecule B.  For simplicity, only V243 is 
highlighted on the PAS A beta sheet  A. Each of the four dimers has one 
PAS A/αF interaction wherein the central PAS A hydrophobic residue, 
Val243, sits between Met560 and M564  B. The second PAS A/αF 





A.     
B.     
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    4.6 The position of the perLong point mutation residue (V243) 
 
The residue V243 sits at the center of the hydrophobic intermolecular PAS 
A/αF interaction.  A close look at the interactions between this residue and 
the interacting F helix residues (in both positions described above) indicates 
that mutation of this Valine to Aspartic Acid would strongly disrupt the 
interaction.  The observed effects of this mutation on PER 229-575 
dimerization and stability in vitro is described in Parts 3 and 5.   
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4.7 Residues associated with TIM binding and cytoplasmic localization 
 
Some residues depicted in the PER 229-575 crystal structure have been 
identified previously as necessary for TIM binding.  These include residues 
233-390 (the PAS A domain) and residues 448-512 (the PAS B beta sheet) 
[83, 84].  
 
Figure 4.7.1.   Regions of PER 229-575 previously identified as necessary 
for TIM binding and cytoplasmic localization.  A. Residues associated with  














A PER fragment including the PAS AB domain region and beyond (233-
685) and another PER fragment including only the PAS A domain (233-390) 
have been shown to bind TIM in yeast two-hybrid assays [83, 84].  GST pull 
downs of PER expressed in E. coli have also demonstrated interactions 
between these PER fragments and TIM.  This indicates that TIM-binding 
residues in PER are near to and may overlap with residues of the PAS A beta 
sheet shown in the crystal structure to participate in the PAS A/αF 
interaction.  It is interesting to consider the PAS A/αF interaction as one that 
may affect (and be affected by) PER-TIM binding.  This is discussed further 
in Part 6. 
 
The PAS B residues that bind TIM fragments in vitro (448-512) also act as a 
cytoplasmic localization domain (CLD) [83, 84].  In the absence of TIM, 
residues 448-512 keep otherwise nuclear PER in the cytoplasm.   This is 
shown by the nuclear entry of PER Δ448-512 expressed in S2 insect cell 
culture (without TIM) versus wild type PER, which remains in the 
cytoplasm when expressed without TIM.   It is proposed that the PER CLD 
binds some cytoplasmic element and that the binding interface is missing in 
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the PER Δ448-512 mutant and covered when PER binds TIM to prohibit the 
cytoplasmic interaction and promote nuclear entry.  Because PER Δ448-512 
is missing a critical structural element, its localization is difficult to interpret, 
and binding between 448-512 and Tim fragments in vitro involves isolated 
beta strands that may behave differently out of the context of the larger 
domain.  The proposition, however, that the CLD (Pas B beta sheet) acts as a 
competitive binding interface is consistent with the typical role of the PAS 
beta sheet as a binding surface.  
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PART 5: Oligomerization of PER fragments in solution  
 
The oligomeric state of a protein can be found by comparing the weight of 
the monomer as determined by SDS PAGE analysis to the weight of the 
native protein as indicated by its elution volume from a gel sizing column.  
All PER fragments selected for purification on a large scale (listed in Table 
3.1) were run on such columns to determine their oligomeric state.  None of 
these proteins eluted from the columns at volumes consistent with  
monomers, and most ran between trimer and tetramer size. Mutant versions 
of the PER 229-575 fragments were also assayed by this method.  Mutations 
were designed to interfere with the PAS A/αF intermolecular interaction 
seen in the crystal structure. The effects of these mutations on the 
interactions between PER fragments in solution are consistent with the 
placement of mutated residues in the crystal structure.  
 
5.1 Larger PER fragments behave as oligomers 
 
Larger PER fragments, including 1-575, 1-700, 1-848, and even the slightly 
larger 147-573 run at elution volumes indicating molecular weights near 
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trimer size, rather than as dimers.  These fragments may also be dimers that 
because of their structure run at a larger size.  Consistent with this, larger 
fragments combined with 229-575 and run on gel sizing chromatography 
produce only one additional peak that exhibits a 1:1 ratio of proteins (see 
section 5.2).   Proteins that include the N-terminus and end at 575 (1-575, 
147-573) run even larger than those that include both the N-terminus and 
residues beyond 575 (1-700, 1-848), consistent with the possibility of a 
compacting interaction between the N-terminus and the region following 
575, as discussed in section 3.2. 
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Figure 5.1.1.   PER 1-575, 1-700, and 1-848 run as oligomers on Superdex 
200 sizing columns.  A. PER 1-575, a 63 kD protein, elutes from a Superdex 
200 column at a volume consistent with a molecular weight of 
approximately 220 kD.  B. PER 1-848, a 93 kD protein, runs at a volume 
consistent with a weight of approximately 360 kD. C. PER 147-575, a 47 kD 





A.                 B. 
C. 
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5.2 PER 229-575 runs near dimer size and recombines with larger 
fragments in a 1:1 ratio. 
 
The PAS domain region fragment (229-575) runs close to dimer size, (see 
Figure 3.3.1).  Larger fragments, when combined with the crystallized PAS 
region fragment (229-575), recombine into complexes with a 1:1 ratio, as 
shown by densitometry analysis of SDS PAGE peaks.  A combined peak 
elutes from gel sizing columns in between the peak for the large protein and 
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Figure 5.2.1.   PER 229-575 forms complexes with larger PER fragments.  
A. PER 1-848 + PER 229-575 shows three peaks on a chromatogram B. 
SDS PAGE analysis shows the first peak is 1-848, the second peak is a 
combination of 229-575 and 1-848, and the third is 229-575.   B. The same 
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5.3 Mutations of residues involved in the PAS A/αF interaction 
observed in the crystal structure affect the monomer/dimer equilibrium 
of PER 229-575. 
 
On the PAS A beta sheet, the V243D mutation inserts a large charged 
residue into the hydrophobic center, where αF of the interacting protein sits 
in the crystal structure.  In solution, this mutation strongly hinders 
dimerization (see Part 3, Figure 3.3.3) and stability of PER 229-575. 
 
On the F helix, the key hydrophobic residues that interact with the PAS A 
beta sheet of the interacting protein are L556, M560 and M564.  As 
discussed in Part 4.5, αF is found in two positions.  In position 1, L556 and 
M560 are the key interactive residues flanking V243 of the opposing beta 
sheet.  In position 2, the M560 and M564 flank V243.  Mutating any of these 
residues to alanine does not strongly affect the dimerization of PER 229-575 
in solution. The shift of the protein peak toward monomer is minimal (an 
elution shift from 1.5 to 1.51 or 1.52 ml).   Mutating M560 (which interacts 
withV243 in both observed positions) to alanine does not alter the position 
of the dimer peak but produces an unusual peak near the void volume of the 
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gel sizing column.  Protein from this peak merits further investigation to 
determine whether it is a contaminant, such as heat shock protein, or a larger 
PER oligomer.   
 
Figure 5.3.1.   PER 229-575 αF mutants are not significantly affected in 
their monomer-dimer equilibrium.  A. PER 229-575 elutes from a  Superdex 
200 sizing column at a volume consistent with the molecular weight of the 
dimer.  B. PER 229-575 L556A behaves similarly. C. PER 229-575 M560A 
runs as a dimer, but a large peak near the void volume merits further 
investigation D. Per 229-575 M564A runs similarly to wild type and L556A. 
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5.4 The monomer-dimer equilibrium of PER 229-575 in solution is 
affected by ionic strength. 
 
In 50mM Tris pH7.5, 500mM NaCl, 2mM DTT, PER 229-575 runs as a 
dimer with an elution volume of 1.47ml.  In the same buffer, with 150mM 
NaCl, some monomer is evident with a elution peak at 1.50 ml.  Reducing 
the salt concentration of the buffer further monomerizes PER 229-575.   The 
positive effect of ionic strength on dimerization suggests that dimerization in 
solution depends on hydrophobic interactions, such as those seen in the 
crystal structure.   The higher concentration of the PER run in 150mM salt 
does not contribute to differences in elution volume.  Changing the 
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Figure 5.4.1.   The molecular weight of PER 229-575 complexes in four 
different NaCl concentrations. Lines labeled “D” and “M”  indicate peak 
volumes consistent with the dimeric and monomeric molecular weights.     
A.  Per 229-575 in 50mM Tris pH7.5, 2mM DTT with 150 mM NaCl B. As 
in A, but with 120mM NaCl. C. As in A, but with 90 mM NaCl. D. As in A, 




D   M                         D   M                         
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PART 6: Discussion 
 
PER fragment purification 
In the search for PER fragments that are both interesting and practical for 
purification in large quantities, the problem of nucleic acid binding should 
be considered.  The nucleic acid remaining bound to PER 1-700 after 
purification appears to be RNA, but this may be a consequence of greater 
activity of the DNAse versus RNAse added during cell lysis.  Eliminating 
nucleic acid binding can be accomplished by eliminating the N-terminal 87 
residues of PER.  However, this creates stability problems in PER fragments 
that extend beyond residue 575.   Eliminating nucleic acid binding without 
introducing stability problems may be possible through specific internal 
deletions or mutations of basic N-terminal residues.  Although it is possible 
that the same residues responsible for nucleic acid binding stabilize regions 
beyond residue 575, or that the binding of nucleic acid itself somehow 
stabilizes the protein, it is likely that nucleic acid binding residues could be 
safely eliminated.  The stretch of basic residues which act as the PER 
nuclear localization sequence (NLS) is likely to mediate nucleic acid binding 
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[85].  These residues lie between 60 and 80 as follows: 61 SDMIIKRNKD 
KSRKKKKNKG 80.  An internal deletion, Δ60-80, would eliminate these 
residues but conserve 1-60.   Residues 1-15 of PER are highly conserved and 
may be responsible for stabilizing the PER region beyond 575, in which case 
the problems of both instability and nucleic acid binding could be 
eliminated.  
 
Interactions between the PER N-terminus and the short/mutable region 
The destabilizing effects of the Δ1-87 deletion on regions beyond residue 
575 indicate the PER N-terminus may interact with the short/mutable region 
that lies between 575 and 600.  The effect of Δ1-87 on the stability of 575-
700, which appears to similarly affect 575-692 and 575-848, may also 
depend on a interaction between the N-terminus and some other region of 
PER that indirectly stabilizes the 575-600 region.  In either case, a more 
detailed deletion/mutation analysis of residues 1-87 would allow a more 
precise characterization of the possible interplay between the N-terminus 
and short/mutable region of PER.   
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The PER PAS AB dimer  
The PAS domain region of PER behaves as a dimer both in solution and in 
the crystal structure presented here.  This dimer has four major 
intermolecular interfaces.  The first two are between PAS domains and join 
the PAS A domain of the first molecule with the PAS B domain of the 
second and vice versa (PASA1-PASB2 and PASA2-PASB1).  This creates a 
ring of PAS domains that follows the pattern PASA1-PASB1-PASA2-PASB2. 
 
Figure 6.1.   The PER PAS domain dimer is held together by two types of 
interactions (indicated by yellow asterisks).  A. The PAS A-PAS B interface.  
B. The PAS A-αF interface 
 
A.     B. 
 
 




PER-PER interactions in a PER fragment containing the crystallized region 
(PER 233-685) have also been observed in yeast-two hybrid experiments 
and in in vitro pull down assays [86].  A weaker interaction between the 
PAS A domain of PER (PER 233-390) and a fragment including αF (PER 
524-685)  was also seen.  Immunoprecipitation of full-length HA and Myc-
tagged PER from fly head extracts also indicates that full-length PER 
expressed in flies self-binds, although in limited amounts [87]. 
 
Binding between larger PER fragments expressed in vitro (PER 1-848 and 
PER 1-575) and PER 229-575 indicates that the intermolecular interactions 
that hold together PER 229-575 dimers may be present in the larger 
fragments.   The new complexes formed run at molecular weights between 
those of the larger protein complexes and the smaller 229-575 dimers . The 
ratio of large to small proteins in the new complexes is 1:1.  These new 
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Conservation of the PER PAS ring structure 
The conservation of the PAS-PAS interacting residues of PER (W482, 
G248, S273 and I275) in other PAS A/B tandem repeat proteins, including 
CLK, CYC, mPERs1-3, mCLK, and BMAL1, indicates these proteins may 
also form the type of PAS dimer depicted in Figure 6.1 .  Like PER, these 
PAS AB proteins may require additional intermolecular interfaces for 
dimerization.  Because the F helix is not conserved beyond the insect PERs, 
this interaction is unlikely to act as the secondary interface.  A secondary 
binding interface, if present in other PAS AB proteins, may be specific to the 
individual protein. Alternatively, the PAS-PAS interfaces of other PAS AB 
proteins may be sufficient themselves to dimerize the proteins.  
 
The PAS A/αF intermolecular latching interaction 
Although the PAS A/αF interaction is a critical dimerization interface in the 
PER PAS structure, it also appears to be more dynamic, as seen in its two 
positions in the structure presented here and in the third, outstretched 
position shown in the previous structure.  It is interesting that the four 
dimers that make up the octamer in the previous structure are held together 
by a single PAS A/αF interaction, implying that only one such interaction is 
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required for dimerization.  The loss of 2-3kD from PER 299-575 and, to a 
much greater extent, from PER 229-575 V243D, is consistent with the loss 
of the F-helix beyond the bend (around residue R551).   If the F-helix can 
move into multiple positions, it may be more susceptible to proteolytic 
cleavage.  
 
It is interesting to consider whether the accessibility and the flexibility of the 
F helix are recapitulated to some degree in full-length PER in vivo.   This 
could facilitate access to residues at or around those involved in the 
hydrophobic interface by modifying proteins such as kinases.   
Phosphorylation of helix residues S550, S558, T562, or S568, or of the PAS 
residues Y253 or T343, which sit beneath the helix, could affect the larger 
PER-DBT-TIM complex by reducing PER dimerization. 
 
The perLong residue (V243) 
One example of how a large, negatively charged group inserted into the 
observed PAS A /F hydrophobic interface affects PER self-association is 
seen in PER 229-575 V243D.  This mutation has two major effects on PER 
229-575.  First, it interrupts the PER-PER interaction.  This can be seen by 
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the shift of the peak protein on gel sizing that indicates an increasingly 
monomeric protein.  Second, it increases the 2-3kD degradation of PER.  In 
V243D, the smaller “under band” is far more prevalent, and it runs as a strict 
monomer on gel sizing.  Wild-type PER 229-575 that has degraded in this 
manner continues to run as a single dimer peak on gel sizing columns, so 
that the loss of 2-3kD in V243D does not alone account for monomerization.  
The compromised, though not completely destroyed, dimerization 
interaction of V243D in solution is consistent with the crystal structure, 
because the insertion of an aspartic acid into the PAS A/αF interface would 
likely destabilize the interaction.   
 
The F helix 
Mutations to the key interactive residues of the F-helix (L556A, M560A, 
and M564A) also produce results consistent with the crystal structure.  In 
solution, these mutations do not significantly affect dimerization or stability 
of the PER 229-575 fragment.  In the structure, two positions are observed, 
that may be allowed by the repeated hydrophobic motifs at the three key 
helical turns (555QALASFMETLMD565).   Only two turns of the helix 
participate significantly in the hydrophobic interaction with PAS A, and 
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these can be either L556 and M560 (Position 1) or M560 and M564 
(Position 2).  It also appears that a twist of the helix would not significantly 
disrupt the hydrophobic interface, because L556, M560, and M564 are each 
proceeded by other hydrophobic residues.    
 
The perLong mutation (V243D) 
The biochemical effects of V243D on the PER 229-575 fragment in solution 
and the position of V243 in the 229-575 crystal structure are interesting to 
consider in light of the known in vivo effects of this mutation, known as 
perLong.   This mutation was one of the original circadian mutants 
characterized, and its effects on the circadian rhythm of flies has been well 
documented [11].   The primary effect of perLong is to delay nuclear entry of 
PER and TIM, thereby slowing the period of the clock.  It was once 
speculated that perLong delayed nuclear entry by disrupting the PER-TIM 
interaction, because the perLong mutation is located in the PAS A domain of 
PER, which is also known to be involved in TIM binding [84].   The 
opposite was found to be true, however; perLong enhanced PER-TIM binding 
in Yeast two-hybrid experiments [84].   Studies have also shown that perLong 
does not diminish the stability of PER in vivo, nor does it delay formation of 
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PER/TIM complexes [23, 87]. The yeast two-hybrid result, though positive, 
does suggest some effect of perLong on the PER TIM interaction, but one that 
is subtler than simple disruption or delay.  This effect may delay the release 
of PER from TIM, an event now recognized as a part of nuclear entry and 
one that delayed in perLong [23]. 
 
PER-TIM binding and the PER PAS region 
One model to explain the effects of V243D on PER-TIM binding as well as 
the PAS A/αF interaction is one in which the PASA/αF dimerization 
interaction stabilizes PER during its release from TIM prior to nuclear entry.   
If the PER-TIM interaction (known to involve the PER PAS A domain) 
occupies residues adjacent to or overlapping with the PAS A residues that 
bind αF, the F helix may not rest on the PAS A beta sheet, as it does in the 
structure, when PER is bound to TIM.  The release of PER from TIM, 
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Figure 6.2.   A model of how the PAS A/αF dimerization interaction might 
facilitate the release of PER from TIM that is part of nuclear entry.  
Dimerization of PER facilitates release from TIM by stabilizing free PER.  
A compromised dimerization interface, as in V243D, in this case, would 




Considering V243D as a mutation that may disrupt the release of PER from 
TIM may help explain past observations of an enhanced interaction between 
PER and TIM with V243D at ambient temperatures [84].  This train of 
thought is only possible in light of new information about the separation of 
PER from TIM that occurs during nuclear entry.   The flexible F helix may 
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be able to both reveal and cover the PAS A beta sheet in order to move PER 
in and out of a larger complex with TIM.  A more thorough investigation of 
this interaction based on the study of full length PER expressed in flies or 
cell culture will improve our understanding of the importance of the 
dimerization interfaces seen in the crystal structure presented here and their 
potential effects in PER interactions in vivo.    
 
Testing the in vivo effects of an altered PAS A/αF interaction 
The in vivo effects of a mutation that interrupts the hydrophobic surface of 
the PAS A beta sheet (V243D) have been described in several publications, 
and include a lengthened circadian rhythm associated with a delay in the 
nuclear entry of PER, as well as further lengthening of the circadian period 
and arrhythmicity with increased temperatures.  These effects, however, may 
be caused by effects on interactions other than the self-binding PAS A/αF 
interaction seen in the crystal structure.   A deletion mutation that eliminates 
the F helix (perΔC, which lacks residues 515-568) has also been described 
[88].   This deletion causes a number of effects including delayed nuclear 
entry, lengthening of the circadian period with increased temperature, 
reduced amplitude oscillations of PER, PER hypophosphorylation, and 
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decreased degradation of PER in response to light.   Because the overall 
structure of the protein would be changed by the 515-568 deletion, it is 
difficult to relate its effects directly to an altered PER PAS A/αF interaction.   
Similar problems would arise from other mutations designed to destroy or 
hinder the PAS A/αF interaction.  Another method to test the affects of this 
interaction on PER would be to lock the interaction by engineering a 
disulfide bridge between the PAS A beta sheet and the F-helix to fasten the 
helix into a closed position.   Paired mutations, such as V243C and M560C, 
could be first tested as strongly dimerizing or “locked” in vitro by 
chromatographic analysis and crystal structure determination of the 229-575 
fragment bearing the cysteine mutations.  Observation of full-length PER 
expressed in flies or cell culture and carrying such mutations may also reveal 
increased PER homodimerization.  If PER homodimerization is significantly 
increased in vivo, associated effects on PER-TIM binding or PER nuclear 









The dimerizing interactions between PER proteins revealed in the crystal 
structure and chromatographic analyses presented in this work demonstrate a 
mechanism for protein-protein interactions between tandem PAS domain 
proteins.  These interactions create a ring of four PAS domains latched 
together by dynamic interactions involving an helix outside the PAS 
domains (the F helix).  Based on the sequence conservation of residues 
involved in intra-protein and inter-protein interfaces of the ring, this type of 
structure may also occur in the PER proteins of other species and in other 
tandem PAS proteins.  The latching interaction, however, is not conserved 
beyond insects and may provide a unique means of regulating the 
dimerization of insect PERs.  This interaction is strongly hindered by the 
perL (V243D) mutation, which is known to lengthen circadian rhythms in 
flies by delaying the nuclear entry of PER.  It has been shown that the perL 
mutation does not destabilize PER or hinder the formation PER-TIM 
complexes [23, 86].  It is possible that perL may affect the same interaction 
in vivo seen in the crystal structure, a PER-PER interaction.  If this PER-
PER interaction stabilizes the release of PER from TIM that occurs prior to 
nuclear entry, this could help explain the delay in nuclear entry seen in perL 
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flies.  Tests to demonstrate PER homodimerization in vivo and its 
relationship to the separation of PER from TIM a nuclear would inform this 
model. 
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